Ticagrelor, Prasugrel Compared in ACS Treated With PCI
TUESDAY, July 6, 2021 -- For patients presenting with acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI), a postrandomization subgroup analysis suggests that a prasugrel-based strategy is superior to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Angioplasty | Coronary Angioplasty | Percutaneous Coronary Intervention | Pharmaceuticals